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Background: Influenza virus infection causes significantly higher levels of morbidity and mortality in the elderly.
Studies have shown that impaired immunity in the elderly contributes to the increased susceptibility to influenza
virus infection, however, how aging affects the lung tissue damage and repair has not been completely elucidated.
Methods: Aged (16–18 months old) and young (2–3 months old) mice were infected with influenza virus
intratracheally. Body weight and mortality were monitored. Different days after infection, lung sections were stained
to estimate the overall lung tissue damage and for club cells, pro-SPC+ bronchiolar epithelial cells, alveolar type I
and II cells to quantify their frequencies using automated image analysis algorithms.
Results: Following influenza infection, aged mice lose more weight and die from otherwise sub-lethal influenza
infection in young mice. Although there is no difference in damage and regeneration of club cells between the
young and the aged mice, damage to alveolar type I and II cells (AT1s and AT2s) is exacerbated, and regeneration
of AT2s and their precursors (pro-SPC-positive bronchiolar epithelial cells) is significantly delayed in the aged mice.
We further show that oseltamivir treatment reduces virus load and lung damage, and promotes pulmonary recovery
from infection in the aged mice.
Conclusions: These findings show that aging increases susceptibility of the distal lung epithelium to influenza
infection and delays the emergence of pro-SPC positive progenitor cells during the repair process. Our findings
also shed light on possible approaches to enhance the clinical management of severe influenza pneumonia in
the elderly.
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Influenza A virus infection is a major global health chal-
lenge [1,2]. Although the virus infects people of all ages,
elderly individuals (>75 years old) have more than 10-fold
higher influenza-associated hospitalization and higher mor-
tality compared to other age groups [3]. Studies have* Correspondence: jchen@mit.edu
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unless otherwise stated.shown that a major contributing factor is the impaired
immunity in the elderly including delayed viral clearance
[4], delayed and diminished T-cell responses [5-8], poor
immunological memory [5,6], and reduced cell-mediated
immunity to vaccinations [9,10]. The delayed activation of
adaptive immunity is associated with alterations in
antigen-presenting cell activation in the elderly, leading to
delayed production of cytokines and chemokines [4].
Impaired immunity is likely just one of the critical fac-
tors that render the elderly more vulnerable to influenza-
associated morbidity and mortality. Influenza A virus
infects many cell types in the lung, including club cells
and alveolar type II cells (AT2s) [11,12]. Infected cells can. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to the virus-infected cells can also cause cell death and
tissue damage. The loss of tissue integrity makes the
lungs more susceptible to secondary bacterial infections.
In many cases, by the time of hospitalization, the viral
load is insignificant; morbidity and mortality of patients
are likely caused by the severe lung tissue damage,
pulmonary complications, and secondary bacterial pneu-
monia [13].
Given that the lungs are vital for survival, timely repair
of lung damage following influenza virus infection is
critical for recovery from the infection. Interestingly, evi-
dence suggests that aging is associated with a functional
decline of stem and progenitor cells [14-18], therefore
compromising their roles in tissue maintenance and re-
pair. For example, senescence-related changes in bone
marrow-derived mesenchymal stem cells contribute to
the higher susceptibility of lung fibrosis in the elderly
[19]. BrdU-induced senescence of bronchiolar progeni-
tor club cells results in impaired epithelial regeneration
following naphthalene-induced bronchiolar damage [20].
However, the effect of aging on lung tissue damage and
repair, i.e., the loss and regeneration of various lung epi-
thelial cells, following influenza infection has not been
fully characterized.
The lung comprises many types of epithelial cells that
reside in anatomically distinct regions of the trachea,
bronchioles and alveoli [21]. In the mouse, club (or Clara)
cells, which express SCGB1A1, are the predominant cell
type in the conducting airway, whereas alveolar epithelia
are covered by AT1s and AT2s, expressing podoplanin
(PDPN) and pro-surfactant protein C (pro-SPC), res-
pectively. Club cells are known to exhibit progenitor cell
properties to mediate the maintenance and repair of bron-
chiolar epithelia [22-24]. Recently, we and others show
that club cells also give rise to AT1s and AT2s to repair
alveolar epithelia following severe pulmonary damage
[12,25,26]. We further show that club cell to AT2 diffe-
rentiation goes through two successive intermediates.
Bronchiolar epithelial cells that exhibit club cell morph-
ology and express club cell marker, SCGB1A1, are first
induced to express the AT2 cell marker, pro-SPC, follow-
ing lung injury induced by influenza virus infection or
bleomycin treatment. These cells, referred to as pro-SPC+
bronchiolar epithelial cells (or SBECs), then lose SCGB1A1
expression to give rise to pro-SPC+ cells in the damaged
parenchyma [12,25].
In this study, we used automated image analysis [27]
to quantify the damage and regeneration of club cells,
AT1s, AT2s, and SBECs in young and aged mice follow-
ing influenza infection. Our results show that although
there is no difference in the extent of damage and kinet-
ics of regeneration of club cells between young and aged
mice, damage to AT1s and AT2s is more extensive, andregeneration of AT2s is significantly delayed in aged
mice as compared to young mice. The delayed regener-
ation of AT2s is associated with a prolonged persistence
of SBECs. We further show that oseltamivir treatment
reduces viral load and lung damage, and promotes repair
and recovery from infection in aged mice. These findings
identify cellular defects during the repair of damaged
lung tissue in aged mice, and shed light on possible
approaches for better clinical management of severe in-
fluenza pneumonia in the elderly.
Materials and methods
Mice, influenza virus infection and sample preparation
Female C57BL/6 mice at 2–3 months and 8–9 months of
age were purchased from Centre for Animal Resources,
Singapore and housed in specific pathogen-free BSL2 facil-
ities at National University of Singapore (NUS). The 2–3
month-old mice were allowed to acclimatize for about a
week before they were used in experimentation and are
referred to as “young mice”. The 8–9 month-old mice were
allowed to age until they reached 16–18 months old, and
are referred to as “aged mice”. Mice were anesthetized with
ketamine (100 mg/kg body weight) and infected with in-
fluenza virus A/Puerto Rico/8/34 (H1N1) by intratracheal
instillation (30 PFU/mouse). At the indicated days post-
infection (dpi), mice were sacrificed and lung tissues were
collected. The left lobes were fixed in 10% neutral buffered
formalin solution (Sigma-Aldrich) overnight, processed with
Tissue Processor (Leica, TP1020), and embedded in paraf-
fin blocks. For each lobe, 20 transverse sections of 5 μm
thicknesses were cut with microtome from the middle
part of the lobe with 50 μm in between sections. Sections
were mounted on polylysine-coated slides. Ten sections
were used for hematoxilyn and eosin (H&E) staining, and
10 sections for immunofluorescence. The staining proto-
cols are described in the online data supplement.
The right lobes were used for either lavage or virus
plaque assay. The lavage was collected by flushing the
right lobes with 1 ml of PBS twice. Cells were then centri-
fuged at 4000 rpm at 4°C (Thermal Fisher Scientific) and
red blood cells were lysed with ACK lysing buffer (Life
Technologies) for 90 sec. Cell numbers were counted
under microscopy using a hemocytometer after staining
with trypan blue (Sigma-Aldrich). To quantify virus titers
in the lungs, the lobes were homogenized followed by
centrifugation, and the supernatants were subjected to
plaque assay. All animal experiments were approved by the
Institutional Animal Care and Use Committee at NUS and
Massachusetts Institute of Technology.
Histological staining
Paraffin sections were de-waxed in Histo-Clear solutions
twice (National Diagnostics) and rehydrated first in ab-
solute ethanol three times, and then once each in 90%
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processed according to standard protocol. For immuno-
fluorescence staining, antigen retrieval was performed by
incubating the lung sections with proteinase K solution
(Sigma-Aldrich, 20 mg/ml proteinase K in 50 mM Tris-Cl,
1 mM EDTA, pH 8.0) at 37°C for 30 min. Sections were
then blocked in blocking buffer (3% BSA, 0.2% Triton
X-100 in PBS) for 1 hr. Polyclonal rabbit anti-CCSP
(also known as SCGB1A1) antibody (US Biological, cata-
logue number C5828) was used at 1:100 dilution. Goat
anti-pro-SPC antibody (Santa Cruz Biotechnology, cata-
logue number sc-7706) and goat anti-Podopanin antibody
(R&D Systems, catalogue number AF3244) were used at
1:100 dilution. Incubation was performed at 4°C overnight
in blocking buffer. Secondary Alexa Fluor 488-labeled
donkey anti-rabbit antibody (Invitrogen, catalogue num-
ber A21206) and Alexa Fluor 546-labeled donkey anti-
goat antibody (Invitrogen, catalogue number A11056)
were used at 1:100 dilution. Incubation was performed at
room temperature for 1 hr. Cover slips were mounted on
stained sections with antifade reagent containing DAPI
(Invitrogen).
Image acquisition
MIRAX MIDI system (Carl Zeiss) equipped with bright
field and fluorescence illumination was used to scan the
stained lung sections. Whole-slide scanned images were
captured with Axiocam MR(m) (Carl Zeiss), and converted
to TIFF format with Miraxviewer software (3DHISTECH).
The images used for quantification were down-sampled
eight times from the original images to reduce the compu-
tation time and the use of memory space.
Image analysis
The algorithms for computing infiltration index, club
cell coverage index, AT2 relative density and percentage
of SBEC-containing bronchioles are described previously
[27]. Briefly, infiltration index is defined as the ratio of
infiltrated areas to total alveolar area in H&E stained
lung section images. To identify infiltrated areas with
high nuclei density, an H&E image was converted to
greyscale, and then subsampled by factor of two, four
and eight respectively to form the image pyramid of sub-
sampled images [28]. An intensity threshold was then
applied to identify the dark-colour pixels (representing
nuclei) in each level of the image pyramid. A pixel was
eventually selected only if it was identified as dark-
colour pixel in all levels of the image pyramids. These
pixels were then dilated to form connected infiltrated
areas. Total alveolar area was identified from the original
image by using a size threshold to exclude large empty
blood vessels and bronchioles in the lung sections. The
infiltration index was then computed as the ratio of infil-
trated areas to total alveolar area.Club cell coverage index is the coverage density of
SCGB1A1+ club cells on the interior wall of bronchioles
in immunofluorescent images of lung sections. The boun-
daries of bronchiolar epithelia were identified by first
using Delaunay triangulation [29] to determine clusters of
boundary nuclei with long distance from neighbouring
nuclei, then performing region growing from the centres
of each cluster [30]. Based on SCGB1A1 signal at the
identified boundaries of bronchiolar epithelia, all the bron-
chioles were clustered into high-club-cell-coverage ones
(HC) and low-club-cell-coverage-ones (LC) using Ostu
method [31]. The club cell coverage index was computed
as the ratio of HC-to-LC frequency.
AT2 relative density measures the two dimensional
density of AT2s in immunofluorescent images of lung
sections. To compute it, K-means clustering [32] and
watershed method [33] were used to separate healthy and
damaged areas in the lung section and identify AT2s in
the healthy areas based on SPC signal. The total number
of AT2s was counted. The AT2 relative density was then
computed as the number of AT2s in unit tissue area.
Percentage of SBEC-containing bronchioles among the
total bronchioles is used to quantify the induction of
SBECs. Bronchioles were identified using the same feature
extraction method described in computing club cell cover-
age index. Damaged areas were identified using the same
feature extraction method described in computing AT2
relative density. The SCGB1A1+ and SCGB1A1− SBECs
were then determined by checking the co-localization of
SCGB1A1 and pro-SPC signals at bronchioles in the
damaged areas. The number of total bronchioles and
SBEC-containing bronchioles were then counted respect-
ively. The percentage of SCGB1A1+ and SCGB1A1− SBEC-
containing bronchioles were computed by calculating the
percentage of SCGB1A1+ and SCGB1A1− SBEC-containing
bronchioles to total bronchioles, respectively.
An additional automated computer algorithm was
developed in this study to compute AT1 coverage index
as the ratio of alveolar area covered with PDPN+ AT1s
to total alveolar area. Total alveolar area was identified
by manual thresholding DAPI fluorescence intensities
in immunofluoresecnt images, and dilating using “disk”
operator with 5 pixels in size to create the mask of the
tissue, followed by filtering of small areas less than
10000 pixels, filling holes, and eroding back with same
operator and dimension (Additional file 1: Figure S1).
The alveolar area covered with PDPN+ AT1s was seg-
mented in a similar way by manual thresholding PDPN
fluorescence intensity, and then performing the same
dilation, filtering, hole-filling and erosion process. All
image processing and computation algorithms were im-
plemented using Matlab with image processing toolbox
(Math Works, Inc.). The Matlab codes are available
on request.
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Student t-test was used to determine the statistical signifi-
cance of body weight, infiltration index, AT1 coverage
index, AT2 relative density, club cell coverage index, per-
centage of total SBEC-containing bronchioles, percentage
of SCGB1A1+ and SCGB1A1− subsets between aged and
young mice, and aged mice with and without oseltamivir
treatment. Student t-test was also used to determine the
statistical significance of viral load in the lung between
oseltamivir-treated and untreated aged mice. One-way
ANOVA was used to compare the kinetic profiles of club
cell coverage index between aged and young mice. All sta-
tistics were computed with Matlab (Math Works, Inc.).
Results
Influenza virus infection causes more severe lung disease
in aged mice
Female C57BL/6 mice aged 2–3 months (young mice)
and 16–18 months (aged mice) were infected with influ-
enza virus A/Puerto Rico/8/34 (H1N1, PR8) by intra-
tracheal instillation (30 PFU/mouse). Body weight and
survival of the mice were monitored. Although the
young mice lost up to ~24% of the body weight by 9 days
post infection (dpi), they regained their body weight
completely around 18 dpi (Figure 1A). In contrast, the
aged mice continuously lost weight and by 21 dpi the body
weight was reduced by ~37%. Furthermore, the sublethal
challenge dose of influenza virus in the young mice caused
significant mortality in the aged mice, which started to die
at 12 dpi, and ~40% were dead by 21 dpi (Figure 1B). Thus,
influenza virus infection causes more severe disease in the
aged mice.
To quantify lung damage and repair, lungs were har-
vested before infection (control) and at 3, 6, 9, 12, 15, 18,
21 dpi, stained with H&E, and analysed for inflammatory
cell infiltration. The infiltration index is defined as the
ratio of infiltrated areas to total alveolar areas in H&E
images of lung sections (see Materials and methods for
more detail). In young mice, infiltration in the alveolar
region was detected 6 dpi and reached the peak level
of ~75% of alveolar region 12 dpi. Thereafter, infiltrating
cells disappeared rapidly and only ~15% of the alveolar
region was still infiltrated by 21 dpi (Figure 1C, E-H). In
the aged mice, the kinetics of initial infiltration was similar
to that in young mice. However, the peak level of infil-
tration in the aged mice was significantly higher (~80%)
at 12 dpi and persisted until 15 dpi. In addition, a much
slower reduction was observed thereafter, i.e. ~36%
of the alveolar region was still infiltrated by 21 dpi
(Figure 1C, I-L). Inflammatory cell infiltration was also
assayed by counting the number of nucleated cells in
the bronchioalveolar lavage fluid (BALF). Although cell
numbers in both aged and young mice reached the peak
level (1.5 × 106) at 12 dpi, approximately 5-fold morecells were recovered in the BALF from the aged mice
than the young mice at 15 dpi (Figure 1D). Thus, com-
pared to the young mice, influenza virus infection also
causes prolonged inflammatory cell infiltration in the
lungs of the aged mice, consistent with the more severe
disease.
Aged mice sustain more extensive loss of AT1 and AT2 cells,
and delayed recovery of AT2s
To compare damage and repair of bronchiolar and
alveolar epithelia between young and aged mice, we quan-
tified the changes of club cells, AT1s and AT2s over time
by calculating the club cell coverage index, AT1 coverage
index and AT2 relative density [27]. All three indices were
based on analysis of immunofluorescent images of lung
sections (see Materials and methods for details) in order
to preserve spatial relationships among different cell types
in the tissue.
Club cell coverage index is the density of club cells on
the interior wall of bronchioles. In healthy lungs, the
majority of bronchiolar epithelium was covered by
SCGB1A1+ club cells (Figure 2D, E, G, H). The biggest
loss of club cells was observed at 6 dpi, and the full
recovery was completed by 15 dpi in both aged and
young mice (Figure 2A, F, I, K, N). No significant differ-
ence in club cell coverage index was observed at any
time-point following infection between aged and young
mice (p > 0.05 by one-way ANOVA), indicating that loss
of club cells and regeneration of club cells following in-
fection were similar between aged and young mice.
AT1 coverage index is the ratio of AT1-covered alveo-
lar areas to total alveolar areas. In healthy lungs, over
95% of alveolar epithelial surface was covered by PDPN+
AT1s (Figure 2P, Q, T, U) [34], with pro-SPC+ AT2s scat-
tered uniformly (Figure 2D, E, G, H). Following influenza
infection, AT1 coverage decreased in both aged and young
mice (Figure 2B, R, V). However, the magnitude of AT1
cell loss was significantly larger in the aged mice than the
young mice at all time-points except 9 dpi. AT1 coverage
increased from 15 to 18 and 21 dpi (Figure 2B, S, W), but
the similar difference was maintained between the aged
and young mice, suggesting similar kinetics of AT1 regen-
eration in both age groups.
AT2 relative density is the number of pro-SPC+ AT2s
per unit tissue area. Before infection, AT2 relative density
was ~1100 cells per mm2 tissue area in both aged and
young mice. The density decreased following infection,
and reached ~480 cells/mm2 at 9 dpi in young mice
(Figure 2C, J). Subsequently, AT2 density recovered gra-
dually and reached the pre-infection level by 21 dpi in
the young mice (Figure 2C, L). In contrast, AT2 relative
density in the aged mice decreased continuously to ~210
cells/mm2 by 15 dpi (Figure 2C, N). Even at 21 dpi, the
AT2 density was only ~340 cells/mm2 (Figure 2C, O).
Figure 1 Influenza virus infection causes more severe pulmonary disease in aged mice. A. Body weight change in aged (square) and
young (triangular) mice following influenza infection. B. Survival in aged (square) and young (triangular) mice following influenza infection. N=15
for both aged and young mice. C. Infiltration index in aged (solid column) and young (open column) mice following influenza infection. Ten
aged and 10 young mice were used for each time-point. D. Cell number in BALF (after lysis of RBC) in aged (solid column) and young (open column)
mice following influenza infection. Five aged and 5 young mice were used for each time-point. All error bars represent standard errors. *p<0.05,
**p<0.01 by Student t-test. E-H. Representative H&E images of lung sections of young mice before infection (E), and at 12 (F), 15 (G), and 21 (H) dpi.
I-L. Representative H&E images of lung sections of aged mice before infection (I), and at 12 (J), 15 (K), and 21 (L) dpi. Scale bar: 500 μm.
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aged mice lose more AT2s and exhibit delayed AT2 regen-
eration following influenza virus pneumonia.
The induction of SBECs is reduced but the duration is
prolonged in aged mice
The similar loss and regeneration of club cells between
young and aged mice, but delayed regeneration of AT2s
in aged mice suggests delayed club cell to AT2 differenti-
ation in aged mice following influenza viral pneumonia.
Following infection, club cells are induced to differentiate
into AT2s via SBECs [12,25], and we therefore compared
the induction of SBECs [27] between aged and youngmice. The induction of SBECs is quantified as the per-
centage of SBEC-containing bronchioles among the total
bronchioles, measured in immunofluorescent images of
lung sections (see Materials and methods for details).
In both groups of animals, SBECs (pro-SPC+ cells in
the bronchiolar epithelia) started to appear at 6 dpi
(Figure 3A). In the young mice, the percentage of
total SBEC-containing bronchioles (both SCGB1A1+ and
SCGB1A1− subsets) peaked at 12 dpi with ~35% of
total bronchioles containing SBECs (Figure 3A, D).
However, in the aged mice, the percentage of total SBEC-
containing bronchioles peaked later at 15 dpi and with a
significantly lower percentage (~28%) (Figure 3A, J). After
Figure 2 (See legend on next page.)
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Figure 2 Comparison of loss and recovery of club cells, AT1s and AT2s between aged and young mice following influenza pneumonia.
A-C. Club cell coverage index (A), AT1 coverage index (B), and AT2 density (number per mm2 tissue area) (C) in aged (square) and young
(triangular) mice following influenza infection. All error bars represent standard errors. *p < 0.05, **p < 0.01 by Student t-test. D-W. Representative
immunofluorescence staining of lung sections for SCGB1A1 (green) and pro-SPC (red) in D-O (DAPI stain is shown in blue in E and H), and PDPN
(red) and DAPI (blue) in P-W at the indicated time-points following influenza infection. The boxed areas in D, G, P and T are shown in higher
magnification in E, H, Q and U, respectively. The arrows point to loss of SCGB1A1-expressing club cells; in D-O the dotted lines circle the regions
with loss of pro-SPC-expressing AT2s; in P-W the dotted lines circle the regions with loss of PDPN-expressing AT1s . Scale bars are 500 μm for the
low magnification images, and 50 μm for the high magnification images. Ten aged and 10 young mice were used for each time-point.
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SBEC-containing bronchioles decreased rapidly in young
mice and was only ~4% by 21 dpi (Figure 3A, G). In
contrast, the decrease was slower in the aged mice,
and ~12% of bronchioles still contained SBECs by 21
dpi (Figure 3A, K).Figure 3 Induction of SBECs in aged and young mice following influe
bronchioles (both SCGB1A1+ and SCGB1A1− subset) in aged (square) and y
of SCGB1A1+ SBEC-containing bronchioles in the aged (solid column) and
SBEC-containing bronchioles in the aged (solid column) and the young (op
time-point. All error bars represent standard errors. *p < 0.05, **p < 0.01 by
sections for SCGB1A1 (green) and pro-SPC (red) at the indicated time-poin
areas in D and H are shown at higher magnification in E and I, respectively
respectively. Scale bars are 500 μm for the low magnification images, and 5We further quantified SCGB1A1+ and SCGB1A1− sub-
sets of SBECs separately. In both the aged and young mice,
SCGB1A1+ SBECs started to appear at 6 dpi followed by
SCGB1A1− SBECs at 9 dpi (Figure 3B). In young mice,
the percentage of SCGB1A1+ SBEC-containing bronchioles
peaked at ~19% by 12 dpi, followed by a rapid decrease,nza pneumonia. A. The percentage of total SBEC-containing
oung (triangular) mice following influenza infection. B. The percentage
the young (open column) mice. C. The percentage of SCGB1A1−
en column) mice. Ten aged and 10 young mice were used for each
Student t-test. D-K. Representative immunofluorescent staining of lung
ts following influenza infection (DAPI staining not shown). The boxed
. Solid and open arrowheads point to SCGB1A1+ and SCGB1A1− SBECs,
0 μm for the high magnification images.
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In aged mice, the peak percentage of SCGB1A1+ SBEC-
containing bronchioles was slightly lower at ~16%, but
lasted longer from 12 to 15 dpi before a rapid decrease
to ~4% by 21 dpi (Figure 3B, H-K). In young mice, the
percentage of SCGB1A1− SBEC-containing bronchioles
peaked at ~27% at 12 dpi, and gradually decreased to ~4%
by 21 dpi (Figure 3C, D-G). In aged mice, the percentage
of SCGB1A1− SBEC-containing bronchioles peaked at a
similar level (~24%) but later at 15 dpi, and remained
higher (~11%) by 21 dpi (Figure 3C, H-K), consistent with
the sustained levels of SCGB1A1+ SBECs from 12 to 15
dpi. These results indicate that differentiation from club
cells to AT2s is delayed at the intermediate stage of SBECs
in the aged mice.
Oseltamivir treatment of the aged mice reduces damage
to club cells, AT1s, AT2s and SBECs
We investigated the effect of the anti-influenza agent osel-
tamivir on lung damage and regeneration. Aged mice were
infected intratracheally, and given PBS (untreated control)
or oseltamivir (150 mg/kg body weight) intraperitoneally
every 12 hrs for 5 days starting at 2 dpi. Mice were moni-
tored for body weight every 3 days, and euthanized for
measuring viral load at 6 dpi and for lung histology at 6,
12 and 21 dpi. As expected, oseltamivir treatment reduced
the virus titer in the lung by ~2 fold at 6 dpi (Figure 4A).
Oseltamivir-treated mice also lost less weight and started
to recover earlier (Figure 4B). Inflammatory cell infiltra-
tion into the lungs (Figure 4C) at 6, 12, and 21 dpi was
significantly diminished in the oseltamivir-treated mice
(Figure 4G-I) than in untreated aged mice (Figure 4D-F).
Corresponding to the reduced disease severity fol-
lowing oseltamivir treatment, club cell coverage index
(Figure 5A), AT1 coverage index (Figure 5B) and AT2
relative density (Figure 5C) at 6 dpi were all significantly
higher in the treated mice (Figure 5G-I, 5 M-O) than in
untreated mice (Figure 5D-F, 5 J-L). Similarly, significantly
higher levels of AT1 coverage index and AT2 relative
density were observed in the treated mice at 12 and 21
dpi. The induction of SBECs, SCGB1A1+ and SCGB1A1−
subsets was significantly lower in the treated mice than in
untreated mice at 21 dpi (Figure 6). At 12 dpi, although
the percentage of total SBEC-containing bronchioles,
SCGB1A1+ and SCGB1A1− subsets were lower in the
treated mice than in untreated mice, the difference
was only significant for SCGB1A1− subset. Thus, the
reduced disease severity following oseltamivir treat-
ment of the aged mice is correlated with decreased
damage of club cells, AT1s, AT2s and SBECs.
Discussion
Following influenza virus infection, elderly patients suffer
from a much higher rate of hospitalization and mortalitythan individuals from other age groups [3,35-38]. Similar
to humans, influenza virus infection also induces much
more severe disease in aged mice than young mice. Com-
pared to young mice which exhibited only transient
weight loss following influenza pneumonia, the aged mice
continued to lose weight even at 21 dpi. The sublethal
dose of influenza H1N1 virus in the young mice led to
40% mortality of the aged mice by 21 dpi. The more
severe disease in the aged mice correlated with higher and
prolonged inflammatory cell infiltration in the lung and in
the BALF, consistent with previous reports [4,7,8].
Reproducing the increased morbidity and mortality in
the aged mice provides a model system to investigate the
effect of aging in lung damage and repair following influ-
enza infection at the cellular level. We compared the
damage of major lung cell types, including club cells,
AT1s, AT2s and SBECs, and monitored their recovery
over time between young and aged mice. We used histo-
logical analysis because it preserves spatial relationships
among different cell types in the tissue [27]. In addition,
loss of histological staining has been associated with loss
of specific cell types. For example, dead or dying club
cells slough off into the airway lumen, resulting in the
loss of SCGB1A1 expression along the bronchiolar epi-
thelia [12,27,39]. Loss of PDPN expression is associated
with loss of AT1s in many lung injury models [40,41].
Similarly, loss of pro-SPC expression following influenza
infection is due to depletion of AT2s as indicated by
genetic tracing in rCCSP-rtTA:tetO-Cre:ACTB-mT-EGFP
transgenic mice [12]. Thus, the damage and recovery of
club cells, AT1s and AT2s can be quantified based on the
expression of their respective protein markers in lung
sections [27].
We show that loss and regeneration of club cells in
bronchiolar epithelia were similar in aged and young
mice following influenza pneumonia. Club cells are known
to possess self-renewal capacity in response to bronchiolar
damage [23,42], and a sub-population of club cells, re-
ferred to as variant club cells, are able to proliferate to give
rise to more club cells in response to naphthalene-induced
injury [42-44]. Our data suggest that aging does not affect
club cell regeneration during the repair of influenza-
induced damage of bronchiolar epithelia.
Our results show that the loss of AT1s was more severe
in the aged than the young mice (Figure 2B). However, the
kinetics of AT1 regeneration appeared to be similar be-
tween the two groups because the same difference in the
level of AT1s was maintained during their recovery. The
loss of AT2s was also significantly more severe in the aged
than the young mice (Figure 2C). Furthermore, the regen-
eration of AT2s was much slower in the aged mice as
there was very little recovery even at 21 dpi. The delayed
regeneration of AT2s compared to AT1s does not support
the long-standing notion that AT2s give rise to AT1s
Figure 4 Oseltamivir treatment reduces disease severity in the aged mice following influenza infection. A. Body weight change in the
aged mice with (square) and without (triangular) oseltamivir treatment following influenza infection. B. Viral load (PFU/g of lung tissue) in the
aged mice with (solid column) and without (open column) oseltamivir treatment following influenza infection. C. Infiltration index in the aged
mice with (solid column) and without (open column) oseltamivir treatment following influenza infection. Five oseltamivir-treated and 5 untreated
aged mice were used for each time-point. All error bars represent standard errors. *p < 0.05, **p < 0.01 by Student t-test. D-F. Representative H&E
images of lung sections of the aged mice without oseltamivir treatment at 6 (D), 12 (E), and 21 (F) dpi. G-I. Representative H&E images of lung
sections of the aged mice with oseltamivir treatment at 6 (G), 12 (H), and 21 (I) dpi. Scale bar: 500 μm.
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logical conditions [45,46], but is consistent with recent
findings that SCGB1A1+ bronchiolar cells could give rise
to AT2s and AT1s during the repair of alveolar epithelia
[12,25,26]. These results show that the aged mice suffer
from much more severe damage of alveolar epithelia as
well as delayed repair following influenza pneumonia.
We have previously shown that club cells differentiate
into AT2s through SCGB1A1+ and then SCGB1A1− SBECs
[12,25]. Consistently, SBECs were induced in both aged
and young mice between 9 to 15 dpi, after club cell regen-
eration (6–15 dpi), and before regeneration of AT2s and
AT1s (15 dpi and beyond). Peak percentage of total SBEC-
containing bronchioles was significantly lower in aged mice
(15 dpi) than young mice (12 dpi) (p < 0.01), indicating im-
paired differentiation from club cells to SBECs (Figure 3A).In the aged mice, high levels of SBECs persisted much
longer (Figure 3A), especially the SCGB1A1− subset
(Figure 3C), suggesting an impaired differentiation from
SBECs to AT2s. These results reveal that aging affects
multiple steps of alveolar epithelial repair, from club
cells to SBECs to AT2s.
We investigated the effect of the anti-influenza agent
oseltamivir on lung damage and repair in the aged mice.
When administered after infection, oseltamivir reduced
the viral load, inflammatory cell infiltration into the
lung, and loss of club cells, AT1s and AT2s in the aged
mice. Associated with the reduced lung damage, induc-
tion of SBECs was also more transient in the treated
mice, indicating more efficient differentiation from club
cells to AT2s. Consistently, oseltamivir-treated mice lost
less weight and experienced lower mortality compared
Figure 5 (See legend on next page.)
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Figure 6 Induction of SBECs in aged mice with and without oseltamivir treatment following influenza infection. A-C. The percentages of
total SBEC- (A), SCGB1A1+ SBEC- (B), and SCGB1A1− SBEC-containing bronchioles (C) in the aged mice with (solid column) and without (open
column) oseltamivir treatment following influenza infection. Five oseltamivir-treated and 5 untreated aged mice were used for each time-point.
All error bars represent standard errors. *p < 0.05, **p < 0.01 by Student t-test. D-G. Representative immunofluorescence staining of lung sections
for SCGB1A1 (green) and pro-SPC (red) at the indicated time-points following influenza infection (DAPI stain was not shown). Scale bars: 500 μm.
(See figure on previous page.)
Figure 5 Comparison of club cell, AT1, and AT2 coverage in oseltamivir-treated and untreated aged mice following influenza infection.
A-C. Club cell coverage index (A), AT1 coverage index (B), and AT2 density (number per mm2 tissue area) (C) in the aged mice with (solid column)
and without (open column) oseltamivir treatment following influenza infection. Five oseltamivir-treated and 5 untreated aged mice were used for each
time-point. All error bars represent standard errors. *p < 0.05, **p < 0.01 by Student t-test. D-O. Representative immunofluorescence staining of lung
sections for SCGB1A1 (green) and pro-SPC (red) in D-I (DAPI stain is not shown), and PDPN (red) and DAPI (blue) in J-O at 6, 12 and 21 dpi. The arrows
point to loss of SCGB1A1-expressing club cells; the insert in D shows a magnified view of a bronchiole with club cell loss; in D-I the dotted lines circle
the regions with loss of pro-SPC-expressing AT2s; in J-O the dotted lines circle the regions with loss of PDPN-expressing AT1s. Scale bar: 500 μm.
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http://respiratory-research.com/content/15/1/116to untreated aged mice (2 out of 5 untreated aged mice
died between 12 to 21 dpi, but none of the 5 treated
aged mice died). These data support the strategy of miti-
gating influenza-associated morbidity and mortality by
ameliorating lung damage via viral load reduction. Anti-
viral agents may achieve their therapeutic effect partly
by mitigating lung injury and promoting timely repair.
The increased susceptibility of the elderly to influenza-
induced morbidity and mortality as well as decreased
responsiveness to influenza vaccination has traditionally
been associated with impaired immunity [47,48]. Our
study in the aged mice clearly shows that exacerbated
lung damage and delayed repair also constitute a signifi-
cant factor contributing to the greater disease sever-
ity. Our study also suggests that antiviral therapy may
also confer beneficial effects by reducing tissue dam-
age [49,50].
Additional file
Additional file 1: Figure S1. Illustration of algorithm for computing
AT1 coverage index A. A section of lung lobe stained with PDPN
antibody (red) and DAPI (blue) B. Segmented nucleus channel from
original image C. Segmented PDPN channel from original image D. Mask
of total alveolar area E. Mask of PDPN + alveolar area.
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